Use of anticholinesterases

ADMED_ACHEI

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N06DA

7890

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

6811

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

6811

diagram downward connector

Include endpoints None

6811

diagram downward connector
ADMED_ACHEI

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 6568 3042 3526
Unadjusted prevalence (%) 2.13 1.75 2.61
Mean age at first event (years) 77.69 77.98 77.44

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.09 6.70 [5.82, 7.72] <1e-100 2531
15 years 0.02 2.60 [2.26, 3.00] 1.6e-39 917
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ADMED_ACHEI – Use of anticholinesterases
GWS hits:

Survival analyses between endpoints

Plot

before Use of anticholinesterases
after Use of anticholinesterases

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of anticholinesterases